A singular base-editing platform for polyfunctional multiplex engineering of immune cells

Skeate JG, Slipek NJ, Lahr WS, Roy S, Wick BJ, Kar B, Chang JW, Stelljes EM, Gilkey AK, Thenge PP, Diers MD, Krueger JB, Niemeyer EM, Lonetree CL, Kluesner MG, Bell JB, Clement K, Provenzano PP, Moriarity BS, Webber BR

View at source ↗Article2 citations

Abstract

Current methods to engineer antigen-specific receptors rely on randomly integrating vectors or double-strand-break-induced targeted integration, both of which pose safety risks. To implement an all-in-one tool for multiplex knockout (KO) and knockin (KI), we expand the use of base editor nickase activity to stimulate homology-directed repair (HDR) and insert clinically relevant chimeric antigen receptors (CARs) into specific loci. Through a novel single-guide RNA design strategy and a DNA template delivered by a recombinant adeno-associated virus, we enhanced the efficiency of ABE8e-stimulated HDR in human T cells. By combining KI of CD19, CD33, or mesothelin-targeting CARs with >95% quadplex gene KO (B2M/CD3E/PDCD1/CISH), we achieve single-step generation of highly functional off-the-shelf CAR T cell products with enhanced function. Importantly, we found no detectable translocations or significant off-target edits and demonstrated efficacy against multiple cancer lines and a suppressive 3D spheroid culture model. This efficient engineering process of "Iterative Nicking for Synchronous Engineered Reprogramming of T cells" (INSERT) establishes a safe, simplified platform for advanced therapeutic CAR T engineering.

Abstract of "A singular base-editing platform for polyfunctional multiplex engineering of immune cells" by Skeate JG, Slipek NJ, Lahr WS et al., https://doi.org/10.1016/j.ymthe.2026.07.033, used under its Creative Commons Attribution license (CC-BY); markup removed, otherwise unmodified.

Record

Archive ID
doi:10.1016/j.ymthe.2026.07.033
Published
Jul 18, 2026
Venue
Molecular therapy : the journal of the American Society of Gene Therapy
DOI
10.1016/j.ymthe.2026.07.033
PubMed
42470099
License
CC-BY
Provenance
europepmc

Topics